Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 9;11:6323–6341. doi: 10.2147/CMAR.S198911

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Cui et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Migration and invasion abilities of TfR1-negative CRC cells were stronger than TfR1-positive cells. (A) In LoVo, the number of migration cells per field was 1642±118 in TfR1-negative cells vs 906±60 in TfR1-positive cells, and the number of invasion cells per field was 1293±39 in TfR1-negative cells vs 579±89 in TfR1-positive cells (**P＜0.01). (B) In RKO, the number of migration cells per field was 905±44 in TfR1-negative cells vs 492±56 cells in TfR1-positive cells (**P＜0.01), and the number of invasion cells per field was 365±24 in TfR1-negative cells vs 153±18 in TfR1-positive cells (***P＜0.001).